haloperidol has been researched along with Low Bone Density in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunimatsu, T | 1 |
| Kimura, J | 1 |
| Funabashi, H | 1 |
| Inoue, T | 1 |
| Seki, T | 1 |
| Howes, O | 1 |
| Smith, S | 1 |
2 other studies available for haloperidol and Low Bone Density
| Article | Year |
|---|---|
The antipsychotics haloperidol and chlorpromazine increase bone metabolism and induce osteopenia in female rats.
Topics: Amino Acids; Animals; Antipsychotic Agents; Bone and Bones; Bone Density; Bone Diseases, Metabolic; | 2010 |
Alendronic acid for antipsychotic-related osteopenia.
Topics: Alendronate; Antipsychotic Agents; Bone Diseases, Metabolic; Female; Haloperidol; Humans; Middle Age | 2004 |